6612 Stock Overview
A nano-medical material company, focuses on the research and development, manufacture, and sale of ophthalmic medical materials in Taiwan and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
ICARES Medicus, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$123.50 |
| 52 Week High | NT$177.00 |
| 52 Week Low | NT$96.36 |
| Beta | 0.76 |
| 1 Month Change | -1.59% |
| 3 Month Change | -20.83% |
| 1 Year Change | 8.25% |
| 3 Year Change | 97.17% |
| 5 Year Change | 56.33% |
| Change since IPO | 169.01% |
Recent News & Updates
Recent updates
Returns On Capital Signal Tricky Times Ahead For ICARES Medicus (GTSM:6612)
Mar 22
ICARES Medicus, Inc. (GTSM:6612) On An Uptrend: Could Fundamentals Be Driving The Stock?
Feb 24Would Shareholders Who Purchased ICARES Medicus' (GTSM:6612) Stock Year Be Happy With The Share price Today?
Jan 12
Here's What To Make Of ICARES Medicus' (GTSM:6612) Returns On Capital
Dec 15ICARES Medicus, Inc.'s (GTSM:6612) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
Nov 24Shareholder Returns
| 6612 | TW Medical Equipment | TW Market | |
|---|---|---|---|
| 7D | 5.6% | 0.3% | 0.4% |
| 1Y | 8.2% | -4.5% | 28.7% |
Return vs Industry: 6612 exceeded the TW Medical Equipment industry which returned -4.5% over the past year.
Return vs Market: 6612 underperformed the TW Market which returned 28.7% over the past year.
Price Volatility
| 6612 volatility | |
|---|---|
| 6612 Average Weekly Movement | 4.4% |
| Medical Equipment Industry Average Movement | 3.8% |
| Market Average Movement | 4.4% |
| 10% most volatile stocks in TW Market | 7.8% |
| 10% least volatile stocks in TW Market | 2.1% |
Stable Share Price: 6612 has not had significant price volatility in the past 3 months compared to the TW market.
Volatility Over Time: 6612's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | n/a | Ih-Houng Loh | www.icaresmedicus.com |
ICARES Medicus, Inc., a nano-medical material company, focuses on the research and development, manufacture, and sale of ophthalmic medical materials in Taiwan and internationally. It provides ophthalmic medical materials, including intraocular lens for the treatment of cataract, myopia, hyperopia, presbyopia, or astigmatism; and surgical implantation systems, as well as related technical services. ICARES Medicus, Inc. was incorporated in 2011 and is based in Zhubei, Taiwan.
ICARES Medicus, Inc. Fundamentals Summary
| 6612 fundamental statistics | |
|---|---|
| Market cap | NT$5.26b |
| Earnings (TTM) | NT$66.08m |
| Revenue (TTM) | NT$742.27m |
79.6x
P/E Ratio7.1x
P/S RatioIs 6612 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 6612 income statement (TTM) | |
|---|---|
| Revenue | NT$742.27m |
| Cost of Revenue | NT$211.33m |
| Gross Profit | NT$530.94m |
| Other Expenses | NT$464.86m |
| Earnings | NT$66.08m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.55 |
| Gross Margin | 71.53% |
| Net Profit Margin | 8.90% |
| Debt/Equity Ratio | 36.6% |
How did 6612 perform over the long term?
See historical performance and comparisonDividends
0.1%
Current Dividend Yield12%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/24 19:45 |
| End of Day Share Price | 2024/12/24 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
ICARES Medicus, Inc. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Zhennan Lee | Jih Sun Securities Investment Consulting Co., Ltd. |
| null null | KGI Securities Co. Ltd. |
| Hsiu Chi Lin | Masterlink Securities Corp. |